Breimer D D
Br J Clin Pharmacol. 1979;8(1):7S-13S. doi: 10.1111/j.1365-2125.1979.tb00449.x.
1 In the management of insomnia with drugs, any action should be restricted to the duration of the night and residual effects should be absent during the day-time. The intermittent type of drug action desired is fundamentally different from drug treatment where a constant effect is sought. 2 Duration of drug action is dependent on the kinetics of distribution and elimination of the parent drug and its effective metabolites. In addition biopharmaceutical factors, such as those which promote a rapid rate of absorption, are important. 3 These considerations serve as a guide for a review of the kinetics and metabolism of various benzodiazepines.
1 在药物治疗失眠时,任何药物作用都应限于夜间,且白天不应有残留效应。所需的间歇性药物作用类型与寻求持续效应的药物治疗有着根本区别。2 药物作用持续时间取决于母体药物及其有效代谢产物的分布和消除动力学。此外,生物药剂学因素,如那些促进快速吸收速率的因素,也很重要。3 这些考虑因素为综述各种苯二氮䓬类药物的动力学和代谢提供了指导。